When Tara Shuman was diagnosed with breast cancer in August 2012, blogging was not the first thing that came to mind. “I put together an email to my friends and family to tell them about my diagnosis, and I realized when writing the email that it was very therapeutic,” Shuman says.
Current lymphoma therapies are a far cry from the mustard gas used more than 50 years ago. More treatment options, including ones that may be more effective and less toxic, are being studied in ongoing clinical trials. “Clinical trials really are the future of lymphoma treatment,” says Ann LaCasce, MD, a medical oncologist in the Adult Lymphoma Program at Dana-Farber/Brigham and Women’s Cancer Center.
One month after undergoing a mammogram live on “Good Morning America,” ABC reporter Amy Robach announced Monday she has been diagnosed with breast cancer and will undergo a double mastectomy later this week. At 40-years old, Robach is among a population of younger women with breast cancer. According to the American Cancer Society, about 5 percent of all breast cancer cases in the United States occur in women age 40 and younger.
More than 228,000 new cases of lung cancer will be diagnosed in the United States in 2013, according to the National Cancer Institute (NCI). With November marking Lung Cancer Awareness Month, Pasi A. Jänne, MD, PhD, director of Dana-Farber’s Lowe Center for Thoracic Oncology, answers some key questions about the disease:
Some people claim that if the fluids and tissues in your body become too acidic – that is, if the concentration of hydrogen in them is too high – your chance of developing cancer increases. Similar claims state that by reducing your intake of certain foods, you can lower your acidity levels, making the body more “alkaline” and less hospitable to cancer.
Breast cancer is the most common cancer among American women, but only 5-10 percent of breast cancer cases are hereditary. Of those cases, roughly 20-25 percent are linked to mutations in the BRCA1 and BRCA2 genes (BRCA stands for BReast CAncer susceptibility). View the infographic below for more on the genetics of breast cancer.
By Karen Lee Sobol I used to think of hospitals as halls of science. But recently I learned the word “clinic” comes from the Greek, meaning “bedside art.” While we’d all rather avoid a visit to a cancer clinic, there’s a lot we can do to make the first visit a productive, positive experience. For my first visit to Dana-Farber, my husband joined me, along with my own wild emotions—anxiety, fear, and fury among them—and four pages of questions. I found that at that first visit, an oncologist gets to know you in two ways: clinically and personally.
Each year, Dana-Farber patients join clinicians, staff, and the Boston Red Sox to share their stories of inspiration and their belief in the research advances at Dana-Farber during the WEEI/NESN Jimmy Fund Radio-Telethon at Fenway Park. This year, nearly 100 patients, including Rayquan Fregeau, who used art and resources from the Betty Ann Blum and Marjorie Blum Pediatric Resource Room to cope with his diagnosis; Debbie Whitmore, a mother of five who hopes for a cure for future generations; and Jack Robinson, who compiled a joke book to help other children during their treatment, shared their experiences battling cancer. Stephen …
Dana-Farber Cancer Institute recently partnered with CancerConnect and Lakshmi Nayak, MD, to answer questions about brain cancer. Nayak is a neuro-oncologist in the Center for Neuro-Oncology at Dana-Farber/Brigham and Women’s Cancer Center and an instructor in neurology at Harvard Medical School. Q: There seems to be some progress concerning treatment of brain tumors, especially immunotherapy. Do you think we will see further advancements in that area, or in other areas? A: Immunotherapy is indeed a hot topic in gliomas. This is largely driven by advances we have seen in the treatment of melanoma. The way these drugs work is to …